Director/PDMR Shareholding

RNS Number : 2095K

GlaxoSmithKline PLC

14 April 2010

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 13 April 2010 of an increase in their notional interests in Ordinary shares at a price of £12.74 per share and Ordinary Share ADRs at a price of $38.86 per ADR following the notional re-investment of the dividend paid to shareholders on 8 April 2010.

	Ordinary shares	ADRs
Mr A P Witty	11,210.92
Mr J S Heslop	4,474.19
Dr M M Slaoui		2,152.57
Mrs C E Bruck Slaoui		65.37
Mr S M Bicknell	443.85
Mr J M Clarke	2,297.64
Mrs D P Connelly		1,163.59
Mr M Dunoyer	1,017.18
Mr E J Gray	1,491.97
Mr S A Hussain	1,796.31
Mr D Learmouth	634.09
Mr W C Louv		779.92
Mr D J Phelan		1,201.07
Dr D Pulman		983.92
Mr D S Redfern	600.82
Mr J R Stéphenne	1,132.10
Ms C Thomas	707.75
Mr D E Troy		1,769.28

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Deputy Company Secretary

14 April 2010

 

END

 

 

RDSQZLFFBZFZBBF